Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Other financing activities (2022 - 2024)

Bio Essence (BIOE) has 3 years of Other financing activities data on record, last reported at -$9323.0 in Q1 2024.

  • For Q1 2024, Other financing activities fell 198.09% year-over-year to -$9323.0; the TTM value through Dec 2024 reached -$9323.0, up 86.32%, while the annual FY2024 figure was -$9323.0, 86.32% up from the prior year.
  • Other financing activities reached -$9323.0 in Q1 2024 per BIOE's latest filing, up from -$20395.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $12780.0 in Q3 2023 and bottomed at -$71732.0 in Q4 2022.
  • Average Other financing activities over 3 years is -$20840.6, with a median of -$9323.0 recorded in 2024.
  • Peak YoY movement for Other financing activities: surged 287.39% in 2023, then crashed 198.09% in 2024.
  • A 3-year view of Other financing activities shows it stood at -$71732.0 in 2022, then soared by 71.57% to -$20395.0 in 2023, then surged by 54.29% to -$9323.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Other financing activities were -$9323.0 in Q1 2024, -$20395.0 in Q4 2023, and $12780.0 in Q3 2023.